Abstract:
Canadian household prescription drug expenditures are studied using the Statistics Canada Family Expenditure Survey masterfiles for periods that include the introduction of provincial `general population' prescription drug programs. Budget shares for non-senior households are examined over time using non-parametric regression, parametric `difference-in-difference' techniques, and quantile regression methods. The evidence suggests that while program effects are muted when there are high deductibles, a non-senior prescription drug subsidy is more redistributive than an equal-cost proportional income transfer, in part because of differential private health insurance coverage by income. This is in contrast to previous evidence on Canadian senior prescription drug subsidies.
Downloads: (external link) http://economics.ca/cgi/xms?jab=v38n1/07.pdf Full text (application/pdf)
Available to subscribers only. Alternative access through JSTOR and Ingenta.
Related works: This item may be available elsewhere in EconPapers: Search for items with the same title.
Canadian Journal of Economics is edited by David Green
More articles in Canadian Journal of Economics from Canadian Economics Association Address: Canadian Economics Association Prof. Steven Ambler, Secretary-Treasurer c/o Olivier Lebert, CEA/CJE/CPP Office C.P. 35006, 1221 Fleury Est Montréal, Québec, Canada H2C 3K4 Contact information at EDIRC. Series data maintained by Prof. Werner Antweiler ().
This site is part of RePEc
and all the data displayed here is part of the RePEc data set.
Is your work missing from RePEc? Here is how to
contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .